Adagio Medical Holdings (ADGM) Cash from Investing Activities (2023 - 2026)
Adagio Medical Holdings (ADGM) posted Cash from Investing Activities of -$2000.0 for Q1 2026, down 100.41% sequentially from $491000.0 in Q4 2025, and up 99.4% YoY from -$1003.0 in Q1 2025.
Adagio Medical Holdings (ADGM) Cash from Investing Activities (2023 - 2026) Analysis & Trends
Adagio Medical Holdings has reported Cash from Investing Activities for 4 years, with the latest figure at -$2000.0 in Q1 2026.
- Quarterly Cash from Investing Activities rose 99.4% year-over-year to -$2000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$424000.0 (up 60.63% YoY) and the FY2025 annual result came in at -$374000.0, up 70.78% from the prior year.
- Cash from Investing Activities eased to -$2000.0 in Q1 2026 per ADGM's latest filing, from $491000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $491000.0 in Q4 2025 and troughed at -$578000.0 in Q3 2024.
- A 4-year average of -$86857.1 and a median of -$20000.0 in 2023 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities sank 106.79% in 2025, then soared 99.4% in 2026.
- Over 4 years, Cash from Investing Activities stood at -$20000.0 in 2023, then plunged by 2790.0% to -$578000.0 in 2024, then soared by 184.95% to $491000.0 in 2025, then tumbled by 100.41% to -$2000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$2000.0, $491000.0, and -$335000.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Adagio Medical Holdings | 14.47 Mn | 14.47 Mn | - | -6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6,000.00 |
| Jun 30, 2026 | -6,000.00 |
| Mar 31, 2026 | -2,000.00 |
| Mar 31, 2026 | -2,000.00 |
| Dec 31, 2025 | 491,000.00 |
| Dec 31, 2025 | 491,000.00 |
| Mar 31, 2025 | -335,000.00 |
| Mar 31, 2025 | -335,000.00 |
| Sep 30, 2024 | -578,000.00 |
| Sep 30, 2024 | -578,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -162,000.00 |
| Mar 31, 2024 | -162,000.00 |
| Dec 31, 2023 | -20,000.00 |
| Dec 31, 2023 | -20,000.00 |